# A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

Study · id `cardio:ct-nct01057407` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01057407](<https://clinicaltrials.gov/study/NCT01057407>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01057407

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

## Technical summary

Registry record NCT01057407. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2010-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 110 participants (enrolled count; ClinicalTrials.gov record NCT01057407, source copy `cardio:ctgov-nct01057407-2015-05-04`, retrieved 2026-10-26)
- Start date: 2010-01 (registry gives no type) (ClinicalTrials.gov record NCT01057407, source copy `cardio:ctgov-nct01057407-2015-05-04`, retrieved 2026-10-26)
- Primary completion: 2010-09 (actual) (ClinicalTrials.gov record NCT01057407, source copy `cardio:ctgov-nct01057407-2015-05-04`, retrieved 2026-10-26)
- Completion: 2010-09 (actual) (ClinicalTrials.gov record NCT01057407, source copy `cardio:ctgov-nct01057407-2015-05-04`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01057407, source copy `cardio:ctgov-nct01057407-2015-05-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01057407-2015-05-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
- Condition: Chronic Kidney Disease
- Condition: Renal Dialysis
- Condition: Renal Insufficiency
- Intervention (Drug): ASP1585
- Intervention (Drug): Sevelamer hydrochloride
- Lead sponsor: Astellas Pharma Inc
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Astellas Pharma Inc (`cardio:org-astellas-pharma-inc`)

## Provenance

Content hash: b8db4cc225e15d0ecddd5555ceef7b2c36f57254d33af22b82d9a7e2468a1ea3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
